Executive Vice President, General Counsel and Secretary · MYRIAD GENETICS INC (MYGN)

Richard Marsh

A named executive officer of MYRIAD GENETICS in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$2,667,401

Salary $508,595Stock awards $1,914,000Bonus $200

FY2018: $2,367,801

5th of 8 named executive officers at Myriad Genetics by FY2019 total.

8 named officers on file for MYRIAD GENETICS, FY2019

Richard Marsh’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • MYGN’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MYRIAD GENETICS’s whole pay program stands against its peers

  • MYRIAD GENETICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MYGN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 16, 2019 (DEF 14A).

Free

Get Richard Marsh’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Richard Marsh compensation by year

MYRIAD GENETICS Summary Compensation Table · all 4 fiscal years held
In US dollars, as MYRIAD GENETICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$479,400$493,782$493,782$508,595
Bonus$512$307$0$200
Stock awards$1,925,438$1,095,000$1,628,500$1,914,000
Option awards$0$0$0$0
Non-equity incentive$218,127$222,202$234,546$231,919
Pension and deferred compensation$0$0$0$0
All other$10,830$10,921$10,973$12,687
Total$2,634,306$1,822,212$2,367,801$2,667,401

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MYRIAD GENETICS INC DEF 14A filed October 16, 2019, accession 0001193125-19-268215, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MYRIAD GENETICS INC filed document, accession 0001193125-19-268215. Every figure is read from that document and cited to the page and table it appears in. Filed October 16, 2019.

$2.6M
$1.8M
$2.4M
$2.7M
FY16
FY17
FY18
FY19
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
PSU40,000$1,111,200—
RSU37,500$1,041,750—
RSU25,000$694,500—
RSU11,269$313,039—

Per the Outstanding Equity Awards at Fiscal Year-End table in MYRIAD GENETICS INC's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

MYRIAD GENETICS’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Mark CaponePresident and Chief Executive Officer and Director$8,896,684
Alexander FordPresident, Myriad Genetic Laboratories$3,231,702
R. Bryan RiggsbeeChief Financial Officer and Treasurer$3,138,983
Jerry LanchburyChief Scientific Officer$2,685,750
Richard Marsh · this pageExecutive Vice President, General Counsel and Secretary$2,667,401
Bernard TobinFormer President of Myriad Autoimmune$2,341,508
Gary KingFormer Executive Vice President International Operations$2,105,155
Nicole LambertWomen’s Health, Oncology, and International$993,788

The full MYRIAD GENETICS compensation record

free company brief

This page is one person within MYRIAD GENETICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MYRIAD GENETICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MYRIAD GENETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Marsh's compensation dossier · One-time report. No refunds.